Arcturus Therapeutics logo
ARCTArcturus Therapeutics
Trade ARCT now
Arcturus Therapeutics primary media

About Arcturus Therapeutics

Arcturus Therapeutics (NASDAQ:ARCT) is a biotechnology company focused on the discovery, development, and commercialization of RNA therapeutics for rare diseases and vaccines. The company leverages its proprietary lipid nanoparticle delivery system and RNA platforms to develop novel therapeutics. Arcturus’s projects include treatments for cystic fibrosis, liver diseases, and a diverse pipeline of mRNA vaccines against infectious diseases. The objective of Arcturus is to harness the potential of RNA therapies to address unmet medical needs and improve patient outcomes through its innovative research and development efforts.

What is ARCT known for?

Snapshot

Public US
Ownership
2008
Year founded
200
Employees
California, United States
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Products and/or services of Arcturus Therapeutics

  • LUNAR-COV19 (ARCT-021), a vaccine candidate designed to prevent COVID-19 using self-amplifying mRNA technology.
  • LUNAR-OTC, aiming to treat Ornithine Transcarbamylase (OTC) Deficiency by delivering OTC mRNA to liver cells.
  • LUNAR-CF, focused on treating Cystic Fibrosis through the delivery of mRNA to the lungs to enable CFTR protein production.
  • ARCT-810, an mRNA therapeutic candidate targeting Ornithine Transcarbamylase Deficiency, utilizing LUNAR lipid-mediated delivery to enhance protein expression.
  • Preclinical pipeline including various mRNA-based therapeutic and vaccine candidates targeting infectious diseases and rare disorders.

Arcturus Therapeutics executive team

  • Mr. Joseph E. Payne M.Sc.Founder, President, CEO & Director
  • Dr. Padmanabh Chivukula Ph.D.Founder, Chief Scientific Officer, COO & Secretary
  • Mr. Lance KurataChief Legal Officer
  • Mr. Joseph RobertsInterim Principal Financial & Accounting Officer and Controller
  • Ms. Neda SafarzadehVice President and Head of IR/PR & Marketing
  • Ms. Natasha O. BowmanChief Human Resources Officer
  • Mr. Kevin T. SkolChief Business Officer
  • Dr. Igor Smolenov M.D., Ph.D.Chief Development Officer
  • Dr. Ye ZhangChief Regulatory Officer
  • Dr. Alan H. Cohen FAAAAI, FAAP, FACAAI, FCCP, M.D.Chief Medical Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.